334 related articles for article (PubMed ID: 19864606)
1. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease.
Graham KL; Zabel BA; Loghavi S; Zuniga LA; Ho PP; Sobel RA; Butcher EC
J Immunol; 2009 Nov; 183(10):6717-23. PubMed ID: 19864606
[TBL] [Abstract][Full Text] [Related]
2. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
3. A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.
Graham KL; Zhang JV; Lewén S; Burke TM; Dang T; Zoudilova M; Sobel RA; Butcher EC; Zabel BA
PLoS One; 2014; 9(12):e112925. PubMed ID: 25437209
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
5. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
6. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
[TBL] [Abstract][Full Text] [Related]
7. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
8. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
[TBL] [Abstract][Full Text] [Related]
9. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
Li H; Nourbakhsh B; Cullimore M; Zhang GX; Rostami A
Eur J Immunol; 2011 Aug; 41(8):2197-206. PubMed ID: 21674475
[TBL] [Abstract][Full Text] [Related]
10. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
Cravens PD; Hussain RZ; Zacharias TE; Ben LH; Herndon E; Vinnakota R; Lambracht-Washington D; Nessler S; Zamvil SS; Eagar TN; Stüve O
J Neuroinflammation; 2011 Jun; 8():73. PubMed ID: 21702922
[TBL] [Abstract][Full Text] [Related]
11. Gpr97/Adgrg3 ameliorates experimental autoimmune encephalomyelitis by regulating cytokine expression.
Wang J; Wang X; Chen X; Lu S; Kuang Y; Fei J; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):666-675. PubMed ID: 29860267
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
Hamilton NH; Banyer JL; Hapel AJ; Mahalingam S; Ramsay AJ; Ramshaw IA; Thomson SA
Scand J Immunol; 2002 Feb; 55(2):171-7. PubMed ID: 11896933
[TBL] [Abstract][Full Text] [Related]
13. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Lee E; Chanamara S; Pleasure D; Soulika AM
J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
[TBL] [Abstract][Full Text] [Related]
15. Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.
Garcia JA; Pino PA; Mizutani M; Cardona SM; Charo IF; Ransohoff RM; Forsthuber TG; Cardona AE
J Immunol; 2013 Aug; 191(3):1063-72. PubMed ID: 23817416
[TBL] [Abstract][Full Text] [Related]
16. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
17. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
Dunn SE; Bhat R; Straus DS; Sobel RA; Axtell R; Johnson A; Nguyen K; Mukundan L; Moshkova M; Dugas JC; Chawla A; Steinman L
J Exp Med; 2010 Aug; 207(8):1599-608. PubMed ID: 20624891
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor.
Zaheer S; Wu Y; Yang X; Ahrens M; Sahu SK; Zaheer A
Neurochem Int; 2012 Feb; 60(3):215-9. PubMed ID: 22226840
[TBL] [Abstract][Full Text] [Related]
20. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
